|
1
|
Sun H, Saeedi P, Karuranga S, Pinkepank M,
Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et
al: IDF diabetes atlas: Global, regional and country-level diabetes
prevalence estimates for 2021 and projections for 2045. Diabetes
Res Clin Pract. 183(109119)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
American Diabetes Association Professional
Practice Committee. 3. Prevention or delay of diabetes and
associated comorbidities: Standards of care in diabetes-2024.
Diabetes Care. 47 (Suppl 1):S43–S51. 2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Xie D, You F, Li C, Zhou D, Yang L and Liu
F: Global regional, and national burden of type 2 diabetes
attributable to dietary factors from 1990 to 2021. Sci Rep.
15(13278)2025.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhou B, Rayner AW, Gregg EW, Sheffer KE,
Carrillo-Larco RM, Bennett JE, Shaw JE, Paciorek CJ, Singleton RK,
Pires AB, et al: Worldwide trends in diabetes prevalence and
treatment from 1990 to 2022: A pooled analysis of 1108
population-representative studies with 141 million participants.
Lancet. 404:2077–2093. 2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng
G, Zhang Y, Shen S and Tong N: Type 2 diabetes mellitus in adults:
Pathogenesis, prevention and therapy. Signal Transduct Target Ther.
9(262)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tuttle KR, Bakris GL, Bilous RW, Chiang
JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K,
Narva AS, Navaneethan SD, et al: Diabetic kidney disease: A report
from an ADA consensus conference. Diabetes Care. 37:2864–2883.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Levey AS, Coresh J, Balk E, Kausz AT,
Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J and Eknoyan G:
National Kidney Foundation. National kidney foundation practice
guidelines for chronic kidney disease: Evaluation, classification,
and stratification. Ann Intern Med. 139:137–147. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kidney Disease. Improving Global Outcomes
(KDIGO) Glomerular Diseases Work Group: KDIGO 2021 clinical
practice guideline for the management of glomerular diseases.
Kidney Int. 100 (4S):S1–S276. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mekonnen BW, Holness JL, Berndorfler BD,
Lombard C and Warwick JM: Individualized calibration of estimated
glomerular filtration rate for serial renal function determination:
A pilot study. Sci Rep. 15(18523)2025.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mallamaci F and Tripepi G: Risk factors of
chronic kidney disease progression: Between old and new concepts. J
Clin Med. 13(678)2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ríos-Silva M, Huerta M, Mendoza-Cano O,
Murillo-Zamora E, Cárdenas Y, Bricio-Barrios JA, Diaz Y and Ibarra
I and Ibarra I: Urinary epidermal growth factor in kidney disease:
A systematic review. Nefrología. 43:413–426. 2023.
|
|
12
|
Awad SF, Huangfu P, Dargham SR, Ajlouni K,
Batieha A, Khader YS, Critchley JA and Abu-Raddad LJ:
Characterizing the type 2 diabetes mellitus epidemic in Jordan up
to 2050. Sci Rep. 10(21001)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ajlouni K, Batieha A, Jaddou H, Khader Y,
Abdo N, El-Khateeb M, Hyassat D and Al-Louzi D: Time trends in
diabetes mellitus in Jordan between 1994 and 2017. Diabet Med.
36:1176–1182. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Al-Dwairi A, Al-Shboul O, Al-U'datt DGF,
Saadeh R, AlQudah M, Khassawneh A, Alfaqih M, Albtoush A, Hweidi A
and Alnemer A: Effect of poor glycemic control on the prevalence
and determinants of anemia and chronic kidney disease among type 2
diabetes mellitus patients in Jordan: An observational
cross-sectional study. PLoS One. 19(e0313627)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Al-Dwairi A, Alfaqih MA, Saadeh RA,
Al-Shboul O, Alqudah M, Khanfar M and Khassawneh A: Lack of
glycemic control in type two diabetes mellitus patients is
associated with reduced serum epidermal growth factor level and
increased insulin resistance. Biomed Rep. 22(5)2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Levey AS, Coresh J, Greene T, Stevens LA,
Zhang YL, Hendriksen S, Kusek JW and Van Lente F: Chronic Kidney
Disease Epidemiology Collaboration. Using standardized serum
creatinine values in the modification of diet in renal disease
study equation for estimating glomerular filtration rate. Ann
Intern Med. 145:247–254. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bursac Z, Gauss CH, Williams DK and Hosmer
DW: Purposeful selection of variables in logistic regression.
Source Code Biol Med. 3(17)2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Grant SW, Hickey GL and Head SJ:
Statistical primer: Multivariable regression considerations and
pitfalls. Eur J Cardiothorac Surg. 55:179–185. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hovind P, Rossing P, Tarnow L, Smidt UM
and Parving HH: Progression of diabetic nephropathy. Kidney Int.
59:702–709. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Efiong EE, Maedler K, Effa E, Osuagwu UL,
Peters E, Ikebiuro JO, Soremekun C, Ihediwa U, Niu J, Fuchs M, et
al: Decoding diabetic kidney disease: A comprehensive review of
interconnected pathways, molecular mediators, and therapeutic
insights. Diabetol Metab Syndr. 17(192)2025.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jiang JJ, Sham TT, Gu XF, Chan CO, Dong
NP, Lim WH, Song GF, Li SM, Mok DK and Ge N: Insights into serum
metabolic biomarkers for early detection of incident diabetic
kidney disease in Chinese patients with type 2 diabetes by random
forest. Aging (Albany NY). 16:3420–3530. 2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Karimi F, Moazamfard M, Taghvaeefar R,
Sohrabipour S, Dehghani A, Azizi R and Dinarvand N: Early detection
of diabetic nephropathy based on urinary and serum biomarkers: An
updated systematic review. Adv Biomed Res. 13(104)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Laranjinha I, Matias P, Mateus S, Aguiar
F, Pereira P, Perneta Santos M, Costa R, Lourenço A, Guia J, Barata
JD and Campos L: Diabetic kidney disease: Is there a
non-albuminuric phenotype in type 2 diabetic patients? Nefrologia.
36:503–509. 2016.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
24
|
Thomas MC, Macisaac RJ, Jerums G, Weekes
A, Moran J, Shaw JE and Atkins RC: Nonalbuminuric renal impairment
in type 2 diabetic patients and in the general population [national
evaluation of the frequency of renal impairment cO-existing with
NIDDM (NEFRON) 11]. Diabetes Care. 32:1497–1502. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
D'Marco L, Guerra-Torres X, Viejo I,
Lopez-Romero L, Yugueros A and Bermídez V: Non-albuminuric diabetic
kidney disease phenotype: Beyond albuminuria. touchREV Endocrinol.
18:102–105. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Naser AY, Alwafi H, Alotaibi B, Salawati
E, Samannodi M, Alsairafi Z, Alanazi AFR and Dairi MS: Prevalence
of chronic kidney diseases in patients with diabetes mellitus in
the middle east: A systematic review and meta-analysis. Int J
Endocrinol. 2021(4572743)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Duan J, Wang C, Liu D, Qiao Y, Pan S,
Jiang D, Zhao Z, Liang L, Tian F, Yu P, et al: Prevalence and risk
factors of chronic kidney disease and diabetic kidney disease in
Chinese rural residents: A cross-sectional survey. Sci Rep.
9(10408)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Abd ElHafeez S, Bolignano D, D'Arrigo G,
Dounousi E, Tripepi G and Zoccali C: Prevalence and burden of
chronic kidney disease among the general population and high-risk
groups in Africa: A systematic review. BMJ Open.
8(e015069)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
de Souza dos Santos C, Aparecida de
Oliveira Duarte Y and Maria Trevisan Zanetta D: Prevalence and
incidence of decreased glomerular filtration rate and its variation
over 6 years: Cohort study SABE 2010-2016. PLoS One.
19(e0294660)2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bramlage P, Lanzinger S, Hess E, Fahrner
S, Heyer CHJ, Friebe M, Buschmann I, Danne T, Holl RW and Seufert
J: Renal function deterioration in adult patients with type-2
diabetes. BMC Nephrol. 21(312)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Waas T, Schulz A, Lotz J, Rossmann H,
Pfeiffer N, Beutel ME, Schmidtmann I, Münzel T, Wild PS and Lackner
KJ: Distribution of estimated glomerular filtration rate and
determinants of its age dependent loss in a German population-based
study. Sci Rep. 11(10165)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bob F, Schiller A, Timar R, Lighezan D,
Schiller O, Timar B, Bujor CG, Munteanu M, Gadalean F, Mihaescu A,
et al: Rapid decline of kidney function in diabetic kidney disease
is associated with high soluble Klotho levels. Nefrologia (Engl
Ed). 39:250–257. 2019.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
33
|
Jiang Y, Cao Q, Hong W, Xu T, Tang M, Li Y
and Xu R: Age and estimated glomerular filtration rate in Chinese
older adults: A cohort study from 2014 to 2020. Front Public
Health. 12(1392903)2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Guppy M, Thomas ET, Glasziou P, Clark J,
Jones M, O'Hara DV and Doust J: Rate of decline in kidney function
with age: A systematic review. BMJ Open. 14(e089783)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Buyadaa O, Salim A, Morton JI, Magliano DJ
and Shaw JE: Rate of decline in kidney function and known
age-of-onset or duration of type 2 diabetes. Sci Rep.
11(14705)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rex N, Melk A and Schmitt R: Cellular
senescence and kidney aging. Clin Sci (Lond). 137:1805–1821.
2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Al-Momany A, Almomani EY, Almomani HY,
Al-Azzam SI and Qablan A: Evaluating kidney function and the
associated risk factors among patients with type 2 diabetes
mellitus: A cross-sectional study at a tertiary hospital in Jordan.
BMJ Open. 13(e073536)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Farah RI, Al-Sabbagh MQ, Momani MS,
Albtoosh A, Arabiat M, Abdulraheem AM, Aljabiri H and Abufaraj M:
Diabetic kidney disease in patients with type 2 diabetes mellitus:
A cross-sectional study. BMC Nephrol. 22(223)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
de Hauteclocque A, Ragot S, Slaoui Y, Gand
E, Miot A, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Roussel R, et
al: The influence of sex on renal function decline in people with
Type 2 diabetes. Diabet Med. 31:1121–1128. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Carrero JJ, Hecking M, Chesnaye NC and
Jager KJ: Sex and gender disparities in the epidemiology and
outcomes of chronic kidney disease. Nat Rev Nephrol. 14:151–164.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gu S, Wang A, Ning G, Zhang L and Mu Y:
Insulin resistance is associated with urinary albumin-creatinine
ratio in normal weight individuals with hypertension and diabetes:
The REACTION study. J Diabetes. 12:406–416. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Muniyappa R and Sowers JR: Role of insulin
resistance in endothelial dysfunction. Rev Endocr Metab Disord.
14:5–12. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Martínez-Díaz I, Martos N, Llorens-Cebrià
C, Álvarez FJ, Bedard PW, Vergara A, Jacobs-Cachá C and Soler MJ:
Endothelin receptor antagonists in kidney disease. Int J Mol Sci.
24(3427)2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Schelling JR: The contribution of
lipotoxicity to diabetic kidney disease. Cells.
11(3236)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Le TQ, Thanh KM, Tran TV, Nguyen DTB,
Nguyen LT, Pham DT, Dam LTP, Hoang MT and Huynh TQ: The correlation
between glycation gap and renal complications in patients with type
2 diabetes mellitus. Diabetes Metab Syndr Obes. 17:333–341.
2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Xu Y, Bergenstal RM, Dunn TC and Ajjan RA:
Addressing shortfalls of laboratory HbA1c using a model
that incorporates red cell lifespan. Elife.
10(e69456)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Wang M and Hng T: HbA1c: More than just a
number. Aust J Gen Pract. 50:628–632. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cheng D, Fei Y, Liu Y, Li J, Xue Q, Wang X
and Wang N: HbA1C variability and the risk of renal status
progression in diabetes mellitus: A meta-analysis. PLoS One.
9(e115509)2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Hu H, Cao C, Han Y and He Y: Triglyceride
affects the association between estimated glomerular filtration
rate and the onset of non-alcoholic fatty liver disease: A second
analysis of a Chinese cohort study. Front Med (Lausanne).
9(984241)2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Pontremoli R, Desideri G, Arca M,
Temporelli PL, Perrone V, Dovizio M, Borghi C and Esposti LD: on
the behalf of Local Health Units Group. Hypertriglyceridemia is
associated with decline of estimated glomerular filtration rate and
risk of end-stage kidney disease in a real-word Italian cohort:
Evidence from the TG-RENAL study. Eur J Intern Med. 111:90–96.
2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Suh SH, Oh TR, Choi HS, Kim CS, Bae EH, Oh
KH, Han SH, Ma SK and Kim SW: Serum triglycerides level is
independently associated with renal outcomes in patients with
non-dialysis chronic kidney disease: Results from KNOW-CKD study.
Front Nutr. 9(1037618)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Gong L, Wang C, Ning G, Wang W, Chen G,
Wan Q, Qin G, Yan L, Wang G, Qin Y, et al: High concentrations of
triglycerides are associated with diabetic kidney disease in
new-onset type 2 diabetes in China: Findings from the China
cardiometabolic disease and cancer cohort (4C) study. Diabetes Obes
Metab. 23:2551–2560. 2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zaman SB, Karim MA, Hossain N, Al Kibria
GM and Islam SMS: Plasma triglycerides as a risk factor for chronic
kidney disease in type 2 diabetes mellitus: Evidence from
northeastern Thailand. Diabetes Res Clin Pract. 138:238–245.
2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Abujbara M, Batieha A, Khader Y, Jaddou H,
El-Khateeb M and Ajlouni K: The prevalence of dyslipidemia among
jordanians. J Lipids. 2018(6298739)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Tozawa M, Iseki K, Iseki C, Oshiro S,
Ikemiya Y and Takishita S: Triglyceride, but not total cholesterol
or low-density lipoprotein cholesterol levels, predict development
of proteinuria. Kidney Int. 62:1743–1749. 2002.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Weldegiorgis M and Woodward M: Elevated
triglycerides and reduced high-density lipoprotein cholesterol are
independently associated with the onset of advanced chronic kidney
disease: A cohort study of 911,360 individuals from the United
Kingdom. BMC Nephrol. 23(312)2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Tu QM, Jin HM and Yang XH: Lipid
abnormality in diabetic kidney disease and potential treatment
advancements. Front Endocrinol (Lausanne).
16(1503711)2025.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Kovesdy CP, Matsushita K, Sang Y,
Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL,
Hirayama A, Landman GWD, et al: Serum potassium and adverse
outcomes across the range of kidney function: A CKD Prognosis
Consortium meta-analysis. Eur Heart J. 39:1535–1542.
2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Kovesdy CP, Appel LJ, Grams ME, Gutekunst
L, McCullough PA, Palmer BF, Pitt B, Sica DA and Townsend RR:
Potassium homeostasis in health and disease: A scientific workshop
cosponsored by the national kidney foundation and the American
society of hypertension. J Am Soc Hypertens. 11:783–800.
2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Nakhoul GN, Huang H, Arrigain S, Jolly SE,
Schold JD, Nally JV Jr and Navaneethan SD: Serum potassium,
end-stage renal disease and mortality in chronic kidney disease. Am
J Nephrol. 41:456–463. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kohsaka S, Okami S, Kanda E, Kashihara N
and Yajima T: Cardiovascular and renal outcomes associated with
hyperkalemia in chronic kidney disease: A hospital-based cohort
study. Mayo Clin Proc Innov Qual Outcomes. 5:274–285.
2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Agiro A, Cook E, Mu F, Greatsinger A, Chen
J, Zhao A, Louden E, Colman E, Desai P and Chertow GM: Hyperkalemia
and risk of CKD progression: A propensity score-matched analysis.
Kidney360. 5:1824–1834. 2024.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Arif Y, Wenziger C, Hsiung JT, Edward A,
Lau WL, Hanna RM, Lee Y, Obi Y, Kovesdy CP, Kalantar-Zadeh K and
Streja E: Association of serum potassium with decline in residual
kidney function in incident hemodialysis patients. Nephrol Dial
Transplant. 37:2234–2240. 2022.PubMed/NCBI View Article : Google Scholar
|
|
64
|
de Rooij ENM, de Fijter JW, Le Cessie S,
Hoorn EJ, Jager KJ, Chesnaye NC, Evans M, Windahl K, Caskey FJ,
Torino C, et al: Serum potassium and risk of death or kidney
replacement therapy in older people with CKD stages 4-5: Eight-year
follow-up. Am J Kidney Dis. 82:257–266.e1. 2023.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Wetmore JB, Yan H, Horne L, Peng Y and
Gilbertson DT: Risk of hyperkalemia from
renin-angiotensin-aldosterone system inhibitors and factors
associated with treatment discontinuities in a real-world
population. Nephrol Dial Transplant. 36:826–839. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
McMahon EJ, Bauer JD, Hawley CM, Isbel NM,
Stowasser M, Johnson DW and Campbell KL: A randomized trial of
dietary sodium restriction in CKD. J Am Soc Nephrol. 24:2096–2103.
2013.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Feteh VF, Choukem SP, Kengne AP, Nebongo
DN and Ngowe-Ngowe M: Anemia in type 2 diabetic patients and
correlation with kidney function in a tertiary care sub-Saharan
African hospital: A cross-sectional study. BMC Nephrol.
17(29)2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Suresh S, Rajvanshi PK and Noguchi CT: The
many facets of erythropoietin physiologic and metabolic response.
Front Physiol. 10(1534)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Matsuoka T, Abe M and Kobayashi H: Iron
metabolism and inflammatory mediators in patients with renal
dysfunction. Int J Mol Sci. 25(3745)2024.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Hamza E, Metzinger L and Metzinger-Le
Meuth V: Uremic toxins affect erythropoiesis during the course of
chronic kidney disease: A review. Cells. 9(2039)2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Altman DG and Royston P: The cost of
dichotomising continuous variables. BMJ. 332(1080)2006.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Sheng L, Bayliss G and Zhuang S: Epidermal
growth factor receptor: A potential therapeutic target for diabetic
kidney disease. Front Pharmacol. 11(598910)2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Ledeganck KJ, den Brinker M, Peeters E,
Verschueren A, De Winter BY, France A, Dotremont H and Trouet D:
The next generation: Urinary epidermal growth factor is associated
with an early decline in kidney function in children and
adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract.
178(108945)2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Tawengi M, Al-Dali Y, Tawengi A, Benter IF
and Akhtar S: Targeting the epidermal growth factor receptor
(EGFR/ErbB) for the potential treatment of renal pathologies. Front
Pharmacol. 15(1394997)2024.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Harris RC: The epidermal growth factor
receptor axis and kidney fibrosis. Curr Opin Nephrol Hypertens.
30:275–279. 2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Tabatabaei-Malazy O, Saeedi Moghaddam S,
Khashayar P, Keykhaei M, Tehrani YS, Malekpour MR, Esfahani Z,
Rashidi MM, Golestani A, Shobeiri P, et al: Regional burden of
chronic kidney disease in North Africa and Middle East during
1990-2019; results from global burden of disease study 2019. Front
Public Health. 10(1015902)2022.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Al Quran TM, Bataineh ZA, Al-Mistarehi AH,
Zein Alaabdin AM, Allan H, Al Qura'an A, Weshah SM, Alanazi AA and
Khader YS: Prevalence and pattern of dyslipidemia and its
associated factors among patients with type 2 diabetes mellitus in
Jordan: A cross-sectional study. Int J Gen Med. 15:7669–7683.
2022.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hamdy O, Al Sifri S, Hassanein M, Al
Dawish M, Al-Dahash RA, Alawadi F, Jarrah N, Ballout H, Hegazi R,
Amin A and Mechanick JI: The transcultural diabetes nutrition
algorithm: A middle eastern version. Front Nutr.
9(899393)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Allatayfeh M, Al Shdaifat A and Mariotti
SP: Status of health-care systems for diabetes mellitus and
diabetic retinopathy in Jordan: Stakeholders and health-care
providers survey. Middle East Afr J Ophthalmol. 30:168–172.
2024.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Al-Maqbali SRS and Mula-Abed WAS:
Comparison between three different equations for the estimation of
glomerular filtration rate in omani patients with type 2 diabetes
mellitus. Sultan Qaboos Univ Med J. 14:e197–e203. 2014.PubMed/NCBI
|
|
81
|
Stanifer JW, Muiru A, Jafar TH and Patel
UD: Chronic kidney disease in low- and middle-income countries.
Nephrol Dial Transplant. 31:868–874. 2016.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Kidney Disease: Improving Global Outcomes
(KDIGO) CKD Work Group: KDIGO 2024 clinical practice guideline for
the evaluation and management of chronic kidney disease. Kidney
Int. 105 (4S):S117–S314. 2024.
|
|
83
|
Rognant N, Lemoine S, Laville M,
Hadj-Aïssa A and Dubourg L: Performance of the chronic kidney
disease epidemiology collaboration equation to estimate glomerular
filtration rate in diabetic patients. Diabetes Care. 34:1320–1322.
2011.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Lingli X, Qing Z and Wenfang X: Diagnostic
value of the modification of diet in renal disease and chronic
kidney disease epidemiology collaboration equations in diabetic
patients: A systematic review and meta-analysis. J Int Med Res.
48(300060520925950)2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Ofori EK, Nketiah-Dwomo I, Tagoe EA,
Amponsah SK, Adams I, Nyarko ENY and Amanquah SD: Comparative
determination of glomerular filtration rate estimation formulae in
type 2 diabetic patients: an observational study. Biomed Res Int.
2024(9532236)2024.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Fazelian S, Moradi F, Agah S, Hoseini A,
Heydari H, Morvaridzadeh M, Omidi A, Pizarro AB, Ghafouri A and
Heshmati J: Effect of omega-3 fatty acids supplementation on
cardio-metabolic and oxidative stress parameters in patients with
chronic kidney disease: A systematic review and meta-analysis. BMC
Nephrol. 22(160)2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Jun M, Zhu B, Tonelli M, Jardine MJ, Patel
A, Neal B, Liyanage T, Keech A, Cass A and Perkovic V: Effects of
fibrates in kidney disease: A systematic review and meta-analysis.
J Am Coll Cardiol. 60:2061–2071. 2012.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Yamada S and Inaba M: Potassium metabolism
and management in patients with CKD. Nutrients.
13(1751)2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Ameh OI, Ekrikpo U, Bello A and Okpechi I:
Current management strategies of chronic kidney disease in
resource-limited countries. Int J Nephrol Renovasc Dis. 13:239–251.
2020.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Isaka Y: Epidermal growth factor as a
prognostic biomarker in chronic kidney diseases. Ann Transl Med. 4
(Suppl 1)(S62)2016.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Tamargo CL, Coca SG, Thiessen Philbrook H,
Hu DG, Ix JH, Shlipak MG, Fried LF, Gutierrez OM, Waikar SS,
Schrauben SJ, et al: The distal nephron biomarkers associate with
diabetic kidney disease progression. JCI insight.
10(e186836)2025.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Mohebi R, Liu Y, Hansen MK, Yavin Y,
Sattar N, Pollock CA, Butler J, Jardine M, Masson S, Heerspink HJL
and Januzzi JL Jr: Insulin growth factor axis and cardio-renal risk
in diabetic kidney disease: An analysis from the CREDENCE trial.
Cardiovasc Diabetol. 22(176)2023.PubMed/NCBI View Article : Google Scholar
|
